Abstract:Background The interaction between pancreatic cancer cells and pancreatic stellate cells plays a pivotal role in the progression of pancreatic cancer. Pyruvate kinase isozyme M2 is a key enzyme in glycolysis. Previous studies have shown that pyruvate kinase isozyme M2 is overexpressed in pancreatic cancer and that it regulates the aggressive behaviors of pancreatic cancer cells. Aims To clarify the role of pyruvate kinase isozyme M2 in the interactions between pancreatic cancer cells and pancreatic stellate cells. Methods Pyruvate kinase isozyme M2-knockdown pancreatic cancer cells (Panc-1 and SUIT-2 cells) and pancreatic stellate cells were generated by the introduction of small interfering RNA-expressing vector against pyruvate kinase isozyme M2. Cell proliferation, migration, and epithelial–mesenchymal transition were examined in vitro. The impact of pyruvate kinase isozyme M2 knockdown on the growth of subcutaneous tumors was examined in nude mice in vivo. Results Pyruvate kinase isozyme M2-kockdown pancreatic cancer cells and pancreatic stellate cells showed decreased proliferation and migration compared to their respective control cells. Pancreatic stellate cell-induced proliferation, migration, and epithelial–mesenchymal transition were inhibited when pyruvate kinase isozyme M2 expression was knocked down in pancreatic cancer cells. In vivo, co-injection of pancreatic stellate cells increased the size of the tumor developed by the control SUIT-2 cells, but the effects were less evident when pyruvate kinase isozyme M2 was knocked down in SUIT-2 cells or pancreatic stellate cells. Conclusions Our results suggested a critical role of pyruvate kinase isozyme M2 in the interaction between pancreatic cancer cells and pancreatic stellate cells.

Pyruvate kinase M2 interacts with nuclear sterol regulatory element–binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma

LncCCAT1 Interaction Protein PKM2 Upregulates SREBP2 Phosphorylation to Promote Osteosarcoma Tumorigenesis by Enhancing the Warburg Effect and Lipogenesis.

Pyruvate Kinase M2 Prevents Apoptosis Via Modulating Bim Stability and Associates with Poor Outcome in Hepatocellular Carcinoma.

PKM2 Promotes Glucose Metabolism Through a Let-7A-5p/stat3/hnrnp-a1 Regulatory Feedback Loop in Breast Cancer Cells

PKM2 Promotes Metastasis by Recruiting Myeloid-Derived Suppressor Cells and Indicates Poor Prognosis for Hepatocellular Carcinoma.

Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics

Regulation and Function of Pyruvate Kinase M2 in Cancer

Role of Pyruvate Kinase M2 and Its Potential Pathogenic Mechanisms in Human Hepatocellular Carcinoma

PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation

Pyruvate Kinase M2 at a Glance.

Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin

Pyruvate Kinase M2 Activates Mtorc1 by Phosphorylating AKT1S1.

Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells

Pyruvate Kinase M2 Coordinates Metabolism Switch Between Glycolysis and Glutaminolysis in Cancer Cells

Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells

Arginine Methylation of SREBP1a Via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.

A newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis

Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis

Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors

Oncoprotein HBXIP Induces PKM2 Via Transcription Factor E2F1 to Promote Cell Proliferation in ER-positive Breast Cancer

Pyruvate Kinase Isozyme M2 Plays a Critical Role in the Interactions Between Pancreatic Stellate Cells and Cancer Cells